Xylo Stock (NASDAQ:MDGS)


OwnershipChart

Previous Close

$2.14

52W Range

$1.54 - $7.17

50D Avg

$2.60

200D Avg

$3.29

Market Cap

$4.47M

Avg Vol (3M)

$13.22K

Beta

1.37

Div Yield

$0.85

MDGS Company Profile


Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it develops, markets, and distributes software for internet users; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, visualization solutions, and resistant cameras; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

Yes

Country

IL

Employees

77

IPO Date

Aug 05, 2015

Website

MDGS Performance


Peer Comparison


TickerCompany
FNAParagon 28, Inc.
INVOINVO Bioscience, Inc.
ICCMIceCure Medical Ltd
NSYSNortech Systems Incorporated
SSKNSTRATA Skin Sciences, Inc.
DCTHDelcath Systems, Inc.
NXLNexalin Technology, Inc.
NUWENuwellis, Inc.
IRIXIRIDEX Corporation
BWAYBrainsWay Ltd.
SRDXSurmodics, Inc.
OSAProSomnus, Inc. Common Stock
RSLSReShape Lifesciences Inc.
BJDXBluejay Diagnostics, Inc.
MOTSMotus GI Holdings, Inc.
TNONTenon Medical, Inc.